Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01204502
What this trial is testing

Suicide Gene Therapy Trial

Who this might be right for
Haploidentical Stem Cell Transplantation
Great Ormond Street Hospital for Children NHS Foundation Trust 2
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Very early researchNot Yet RecruitingNCT06949267
What this trial is testing

IMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-Host Disease
Ruijin Hospital 56
Not applicableEnded earlyNCT02338232
What this trial is testing

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD
Hackensack Meridian Health 32
Not applicableStudy completedNCT04282421
What this trial is testing

Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France

Who this might be right for
Myelofibrosis
Central Hospital, Nancy, France 58
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Not applicableApproved For MarketingNCT03147742
What this trial is testing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Not applicableWithdrawnNCT05968170
What this trial is testing

TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute Myeloid Leukemia+3 more
Neena Kapoor, M.D.
Not applicableUnknownNCT02185261
What this trial is testing

Interferon α for the Therapy of Minimal Residual Disease

Who this might be right for
Leukemia
Peking University People's Hospital 81
Testing effectiveness (Phase 2)Study completedNCT00136903
What this trial is testing

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Vs Host Disease
Mesoblast, Inc. 32
Early research (Phase 1)WithdrawnNCT02526329
What this trial is testing

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Everett Meyer
Testing effectiveness (Phase 2)Looking for participantsNCT07356245
What this trial is testing

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Who this might be right for
T-cell LymphomaGraft Versus Host DiseaseLymphoma, T-Cell+5 more
Jonathan Brammer 44
Testing effectiveness (Phase 2)Study completedNCT00770757
What this trial is testing

CC-4047 (Pomalidomide) for Graft vs. Host Disease

Who this might be right for
Graft vs Host Disease
Washington University School of Medicine 13
Testing effectiveness (Phase 2)Study completedNCT00427557
What this trial is testing

Cellular Therapy With Cord Blood Cells

Who this might be right for
Multiple MyelomaLeukemiaLymphoma
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00792246
What this trial is testing

Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseStem Cell Transplantation
Phillip Brian Smith 5
Testing effectiveness (Phase 2)Looking for participantsNCT07566377
What this trial is testing

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+5 more
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Looking for participantsNCT06657391
What this trial is testing

Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia

Who this might be right for
Transfusion Dependent Thalassemia
Rongrong Liu 396
Testing effectiveness (Phase 2)Ended earlyNCT01925950
What this trial is testing

Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
Chronic Gastrointestinal Graft vs Host Disease
Soligenix 2
Not applicableStudy completedNCT02411474
What this trial is testing

Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD

Who this might be right for
Chronic Graft-versus-host Disease
Yonsei University 21
Next Page